Media-OutReach Newswire The global leader in rabies vaccines, the serum-free iterative rabies vaccine of AIM Vaccine has submitted a pre-application for marketing registration
Media-OutReach Newswire Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
Economy US issues final affirmative countervailing duty determination on frozen warmwater shrimp from Việt Nam
Media-OutReach Newswire Country and Sector Risk Barometer – October 2024 From monetary pivot to fiscal turnaround?
Media-OutReach Newswire Phase III clinical data of AIM Vaccine iterative serum-free rabies vaccine reaches preset goals